DRD2 and Parkinson disease: Dopaminergic system:
b↓ striatal presynaptic DAT binding contralateral to parkinsonian symptomatology with greater reduction in posterior putamen than in anterior putamen or caudate nucleus; normal or ↑ dopamine D2 receptor binding in drug-naïve PD vs. NC